Process for selective derivatization of taxanes
    51.
    发明授权
    Process for selective derivatization of taxanes 失效
    紫杉烷类的选择性衍生化方法

    公开(公告)号:US06291691B1

    公开(公告)日:2001-09-18

    申请号:US09588933

    申请日:2000-06-07

    IPC分类号: C07D30514

    摘要: Processes for the preparation of taxol and other taxanes through selective derivatization of the C(7) and C(10) hydroxyl groups of 10-DAB, particularly a novel process using a new strategy in which the C(10) hydroxyl group is protected or derivatized prior to the C(7) hydroxyl group; and the provision of C(7) and C(10) derivatized 10-DAB compounds.

    摘要翻译: 通过选择性衍生10-DAB的C(7)和C(10)羟基来制备紫杉醇和其他紫杉烷的方法,特别是使用C(10)羟基被保护的新策略的新方法,或 在C(7)羟基之前衍生化; 并提供C(7)和C(10)衍生化的10-DAB化合物。

    Spiroindolinone pyridine derivatives
    52.
    发明授权
    Spiroindolinone pyridine derivatives 失效
    螺吲哚啉酮吡啶衍生物

    公开(公告)号:US07928233B2

    公开(公告)日:2011-04-19

    申请号:US12685748

    申请日:2010-01-12

    IPC分类号: C07D401/04 A61K31/438

    CPC分类号: C07D471/10

    摘要: There are provided compounds of the formula or a pharmaceutically acceptable salt, ester or enantiomer thereof wherein W, X, Y, V, R1 and R2 are as described herein. The compounds have utility as antiproliferative agents, especially, as anticancer agents.

    摘要翻译: 提供下式的化合物或其药学上可接受的盐,酯或对映异构体,其中W,X,Y,V,R 1和R 2如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。

    Spiroindolinone Derivatives
    53.
    发明申请
    Spiroindolinone Derivatives 失效
    螺吲哚啉酮衍生物

    公开(公告)号:US20100210674A1

    公开(公告)日:2010-08-19

    申请号:US12683468

    申请日:2010-01-07

    CPC分类号: C07D471/10

    摘要: There are provided compounds of the formula or a pharmaceutically acceptable salt or ester thereof wherein X, Y, R1, R2 are as herein described.The compounds have utility as antiproliferative agents, especially, as anticancer agents.

    摘要翻译: 提供下式的化合物或其药学上可接受的盐或酯,其中X,Y,R 1,R 2如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。

    Spiroindolinone derivatives
    54.
    发明授权
    Spiroindolinone derivatives 失效
    螺吲哚啉酮衍生物

    公开(公告)号:US07776875B2

    公开(公告)日:2010-08-17

    申请号:US12273035

    申请日:2008-11-18

    IPC分类号: A61K31/438 C07D471/10

    CPC分类号: C07D471/10

    摘要: There are provided compounds of the formula and pharmaceutically acceptable salts and esters and enantiomers thereof wherein W, X, X′, Y, V, V′, A, B and R are as described herein. The compounds have utility as antiproliferative agents, especially, as anticancer agents.

    摘要翻译: 提供下式的化合物及其药学上可接受的盐和酯和对映异构体,其中W,X,X',Y,V,V',A,B和R如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。

    Spiroindolinone Derivatives
    56.
    发明申请
    Spiroindolinone Derivatives 失效
    螺吲哚啉酮衍生物

    公开(公告)号:US20090163512A1

    公开(公告)日:2009-06-25

    申请号:US12273035

    申请日:2008-11-18

    CPC分类号: C07D471/10

    摘要: There are provided compounds of the formula and pharmaceutically acceptable salts and esters and enantiomers thereof wherein W, X, X′, Y, V, V′, A, B and R are as described herein.The compounds have utility as antiproliferative agents, especially, as anticancer agents.

    摘要翻译: 提供下式的化合物及其药学上可接受的盐和酯和对映异构体,其中W,X,X',Y,V,V',A,B和R如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。